MEDICAL DEVICES

The Bactiguard technology prevents infections and increases patient safety.

Proprietary BIP portfolio discontinued

Bactiguard operates through license partnerships with leading global MedTech companies, that apply the technology to their medical devices and sell them under their own brand or co-branded with Bactiguard. Following a strategic review late 2023, it was decided to discontinue Bactiguard’s proprietary BIP product portfolio.

The Bactiguard coated Foley catheters are exclusively offered by license partner Beckton Dickinson & Company globally, apart from China where the Foley catheters are exclusively offered by license partner Well Lead.

For further information about the discontinuation, please contact us here. 

Indwelling urinary catheter that prevents infection

BIP Foley Catheter is an indwelling urinary catheter with the unique Bactiguard technology, which reduces microbial adhesion. Fewer bacteria adhere to the catheter surface, reducing the risk of catheter associated urinary tract infection.

Designed to:

  • Reduce catheter associated urinary tract infection (CAUTI)
  • Reduce use of antibiotics
  • Reduce healthcare costs

Central venous catheter (CVC) that prevents infections

BIP CVC is a central venous catheter with the unique Bactiguard technology, which reduces microbial adhesion. Fewer bacteria adhere to the catheter surface, reducing the risk of catheter related bloodstream infection.

Designed to:

    • Reduce catheter related bloodstream infection (CRBSI)
    • Reduce use of antibiotics

Endotracheal tube that prevents infection

BIP ETT is an endotracheal tube with the unique Bactiguard technology, which reduces microbial adhesion. Fewer bacteria adhere to the tube surface, reducing the risk of VAP.

Designed to:

    • Reduce the risk of ventilator associated pneumonia (VAP)
    • Reduce use of antibiotics
    • Reduce healthcare costs